Parkinson's Disease Trial, Recruiting (NCT06875765)

Parkinson's Disease Trial, Recruiting NCT06875765 Sponsor: Universitaire Ziekenhuizen KU Leuven Condition: Parkinson's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06875765 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Parkinsons Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have already participated in a specific earlier study called S61477 (also known as NCT04243304)

Who may not be able to join:

People who have a neuropsychiatric condition that is not related to their Parkinson's disease (for those with Parkinson's disease) or any neuropsychiatric condition (for other participants)
People who have a serious ongoing internal medical condition
People with a history of alcohol or drug abuse
People who have significant abnormalities detected on a brain MRI scan
People who have a medical reason why they cannot safely have an MRI scan (such as certain metal implants)
People who are pregnant or breastfeeding
People who have taken part in other research studies involving radiation exposure of more than 1 millisievert (a unit used to measure radiation) in the past 12 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +3216344280

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06875765

Sponsor: Universitaire Ziekenhuizen KU Leuven

Phase: Not Applicable

Status: Recruiting

Condition: Parkinson's Disease

Trial contact: +3216344280

More information: https://clinicaltrials.gov/study/NCT06875765

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have already participated in a specific earlier study called S61477 (also known as NCT04243304)

Who may not be able to join:

People who have a neuropsychiatric condition that is not related to their Parkinson's disease (for those with Parkinson's disease) or any neuropsychiatric condition (for other participants)
People who have a serious ongoing internal medical condition
People with a history of alcohol or drug abuse
People who have significant abnormalities detected on a brain MRI scan
People who have a medical reason why they cannot safely have an MRI scan (such as certain metal implants)
People who are pregnant or breastfeeding
People who have taken part in other research studies involving radiation exposure of more than 1 millisievert (a unit used to measure radiation) in the past 12 months

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Universitaire Ziekenhuizen KU Leuven

Registry

ClinicalTrials.gov

Start date

16 July 2025

Est. completion

1 December 2027

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Cross-sectional SV2A at Year 7; Cross-sectional correlation between clinical scores and SV2A at Year 7; Longitudinal SV2A change between baseline and Year 7; Longitudinal correlation between clinical scores and SV2A

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov